However, this process is not instant
Among the N=1,140 large firms responding to the 2022 EHBS, 419 of those responding firms (37%) had any presence in California, highlighting the overlap across these two projects
This suggests that D-HIS exposure may non-specifically decrease the cellular GSH concentration, so resulting in an underestimation of the increase in cellular GSH level potentially attainable with other counter-selection systems
Full disclosure improves safety
Messer says, "individuals who want the anti-inflammatory benefits from the GLP-1 receptor agonists but don't necessarily want to lose any weight might consider this unique option." She adds: "Anecdotally, there appears to be an improvement in food noise and systemic inflammation, but we don't have any long-term prospective trials to prove this." Take Chelsea, a 41-year-old navigating her own wellness journey while living with PCOS